Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [9508]
News [23329]
Articles [1990]
Editorials [134]
Conferences [464]
elearning [298]
Changes in mammographic density
Dr Malcom Pike – Memorial Sloan-Kettering Cancer Center, New York, USA
Changes in mammographic density ( Dr Malcom Pike – Memorial Sloan-Kettering Cancer Center, New York, USA )
17 Oct 2011
Symmetrical and asymmetrical stem cell proliferation
Dr Wenjun Guo – Whitehead Institute for Biomedical Research, Cambridge, USA
Symmetrical and asymmetrical stem cell proliferation ( Dr Wenjun Guo – Whitehead Institute for Biomedical Research, Cambridge, USA )
17 Oct 2011
Cancer risk communication
Carol Maddock - Cancer Communications Researcher, Tenovus
Cancer risk communication ( Carol Maddock - Cancer Communications Researcher, Tenovus )
17 Oct 2011
Cervical cancer and pregnancy in young women
Dr Fabio Landoni – European Institute of Oncology, Milan, Italy
Cervical cancer and pregnancy in young women ( Dr Fabio Landoni – European Institute of Oncology, Milan, Italy )
14 Oct 2011
Treating cancer during pregnancy
Dr Frederic Amant – Katholieke Universiteit, Leuven, Belgium
Treating cancer during pregnancy ( Dr Frederic Amant – Katholieke Universiteit, Leuven, Belgium )
14 Oct 2011
Early treatment in ovarian cancer relapses
Dr Gordon Rustin – Mount Vernon Cancer Centre, Hertfordshire, UK
Early treatment in ovarian cancer relapses ( Dr Gordon Rustin – Mount Vernon Cancer Centre, Hertfordshire, UK )
14 Oct 2011
Targeted treatments in endometrial cancer
Dr Helga Salvesen – Haukeland University Hospital, Bergen, Norway
Targeted treatments in endometrial cancer ( Dr Helga Salvesen – Haukeland University Hospital, Bergen, Norway )
14 Oct 2011
Immunotherapy developments in cervical cancer
Prof Hans Nijman – University Medical Center Groningen, Netherlands
Immunotherapy developments in cervical cancer ( Prof Hans Nijman – University Medical Center Groningen, Netherlands )
14 Oct 2011
Overview of ESGO 2011
Prof Ate van der Zee – President of ESGO, Geneva, Switzerland
Overview of ESGO 2011 ( Prof Ate van der Zee – President of ESGO, Geneva, Switzerland )
14 Oct 2011
Mutations of the SF3B1 gene
Dr Elli Papaemmanuil - Institute of Cancer Research, Sutton, UK
Mutations of the SF3B1 gene ( Dr Elli Papaemmanuil - Institute of Cancer Research, Sutton, UK )
11 Oct 2011
60 years in oncology
Prof Umberto Veronesi - European Institute of Oncology, Milan, Italy
60 years in oncology ( Prof Umberto Veronesi - European Institute of Oncology, Milan, Italy )
6 Oct 2011
Aflibercept vs placebo and FOLFIRI for MCRC
Prof Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Aflibercept vs placebo and FOLFIRI for MCRC ( Prof Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
4 Oct 2011

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation